Multiplexing increases detection of MD genetic effects. (A) Number of variant sites located in regulatory regions that could potentially be tested for ASE when subset for different multiplexing regimes and samples originating from different geographical regions. (B) Maximum number of MD genetic effect sites that would have been present in our assay when subset for different multiplexing regimes and geographical regions.